Other Specified Pulmonary Tuberculosis: Clinical Trials

3 trials for Other Specified Pulmonary Tuberculosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 11Completed 1

Follow Other Specified Pulmonary Tuberculosis: new trials by email Literature Review of Other Specified Pulmonary Tuberculosis trials Research Report on Other Specified Pulmonary Tuberculosis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BTZ-043 Dose Evaluation in Combination and Selection
BTZ-043, Bedaquiline, Delamanid - Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis
Phase 2CompletedMichael Hoelscher922023-09-212026-10-05
PanACEA Sutezolid Dose-finding and Combination Evaluation
Sutezolid, Bedaquiline, Delamanid, Moxifloxacin, Midazolam oral solution - Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis
Phase 2CompletedMichael Hoelscher752021-05-062023-05-01
BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
BTZ-043, Rifafour e-275®, Probe Drug Cocktail - Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis
Phase 1 / Phase 2CompletedMichael Hoelscher782019-11-152026-08-31

Narrower conditions

Tuberculosis (3)  ·  Tuberculosis, Pulmonary (3)  ·  Gram-Positive Bacterial Infections (2)

Broader conditions

Actinomycetales Infections (3)  ·  Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Infections (3)  ·  Lung Diseases (3)  ·  Mycobacterium Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Gram-Positive Bacterial Infections (1)

Interventions

2-(2-methyl-1,4-dioxa-8-azaspiro(4.5)dec-8-yl)-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one (2)  ·  Moxifloxacin (2)  ·  OPC-67683 (2)  ·  bedaquiline (2)  ·  Ethambutol (1)  ·  Isoniazid (1)  ·  Midazolam (1)  ·  PNU-100480 (1)  ·  Pyrazinamide (1)  ·  Rifampin (1)  ·  dolutegravir (1)

Sponsors

Michael Hoelscher (3)

Countries

South Africa (3)  ·  Tanzania (2)

Top investigators

Andreas Diacon, Prof (1)  ·  Michael Hoelscher, Prof (1)  ·  Michael Hoelscher, Prof Dr (1)  ·  Michael Hoelscher, Prof. (1)

Results publications

PMID 39793592, PMID 40645196, PMID 42568101